Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Nanomedicine. 2017 Apr 19;13(6):1983–1992. doi: 10.1016/j.nano.2017.04.005

Figure 3. Inhalation treatment of pulmonary fibrosis.

Figure 3

Changes in body (A) and lung (B) mass and hydroxyproline content in the lungs (C). Pulmonary fibrosis was induced by intratracheal instillation of 1.5 U/kg of bleomycin. Mice were treated with substances indicated twice a week for three weeks starting one day later after the bleomycin administration. At the end of treatment, lungs were harvested, weighted, homogenized and hydroxyproline content in the lungs was measured. Means ± SD are shown. *P < 0.05 when compared with control mice; †P < 0.05 when compared with untreated mice with pulmonary fibrosis.